Optimizing screening for osteoporosis in patients with fragility hip fracture

Clinical Orthopaedics and Related Research

Volumn 469, Issue 7, 2011, Pages 1925-1930

  Roy, Archana ^a   Heckman, Michael G ^a   O'Connor, Mary I ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CYCLOSPORIN; DIURETIC AGENT; FUROSEMIDE; GONADORELIN ANTAGONIST; LEUPRORELIN; LOW MOLECULAR WEIGHT HEPARIN; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; THYROXINE; VITAMIN D;

ADULT; AGED; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; FRAGILITY FRACTURE; HEALTH CARE COST; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; ORTHOPEDICS; OSTEOPOROSIS; PATIENT CARE; PATIENT CARE PLANNING; PATIENT EDUCATION; PRIORITY JOURNAL; SCREENING TEST; VITAMIN D DEFICIENCY;

EID: 79959559296     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-011-1839-5     Document Type: Conference Paper

References (16)

1. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ. 2009; 339:b3692.
2. Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D. Risk of mortality following clinical fractures. Osteoporos Int. 2000;11:556-561.
3. George A, Tracy JK, Meyer WA, Flores RH, Wilson PD, Hochberg MC. Racial differences in bone mineral density in older men. J Bone Miner Res. 2003;18:2238-2244. (Pubitemid 37463318)
4. Heaney RP. Bone mass, bone loss, and osteoporosis prophylaxis. Ann Intern Med. 1998;128:313-314. (Pubitemid 28090764)
5. Janes H, Pepe MS, Gu W. Assessing the value of risk predictions by using risk stratification tables. Ann Intern Med. 2008;149:751-760.
6. Kennel KA, Drake MT. Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clin Proc. 2009;84:632-637; quiz 638.
7. Kok C, Sambrook PN. Secondary osteoporosis in patients with an osteoporotic fracture. Best Pract Res Clin Rheumatol. 2009;23:769-779.
8. Lauderdale DS, Jacobsen SJ, Furner SE, Levy PS, Brody JA, Goldberg J. Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol. 1997;146:502-509. (Pubitemid 27391411)
9. Looker AC, Orwoll ES, Johnston CC Jr, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997;12:1761-1768. (Pubitemid 27500187)
10. National Osteoporosis Foundation. America's Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation. Washington, DC: National Osteoporosis Foundation; 2002.
11. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010.
12. Nelson DA, Jacobsen G, Barondess DA, Parfitt AM. Ethnic differences in regional bone density, hip axis length, and lifestyle variables among healthy black and white men. J Bone Miner Res. 1995;10:782-787.
13. Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2010;153:99-111.
14. Schneider EL, Guralnik JM. The aging of America: impact on health care costs. JAMA. 1990;263:2335-2340. (Pubitemid 20143285)
15. The Joint Commission. Improving and Measuring Osteoporosis Management. Oakbrook Terrace, IL: The Joint Commission; 2007.
16. US Department of Health and Human Services, Office of the Surgeon General. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004.